Prep Biochem Biotechnol. 2005;35(2):119-34.

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.

Source

Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Hospital, Heidelberg, Australia. roger.murphy@ludwig.edu.au

Abstract

The cancer-testis antigen, NY-ESO-1, has been engineered into a bacterial expression plasmid which incorporates a His6-tag. The plasmid was transfected into E. coli strain BL21 and Master and Working cell banks generated from this expression system. Three 15-litre fermentations were performed under cGMP (code of Good Manufacturing Practice) conditions and the crude NY-ESO-1 tagged protein isolated as solubilised inclusion bodies. A three-step cGMP chromatography process (immobilised metal affinity, anion exchange, and hydrophobic interaction) was utilised to purify the protein. The purified NY-ESO-1 is being used in early stage human cancer vaccine trials in Australia and the U.S.A.

PMID:: 15881594; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Expression and purification of cGMP grade NY-ESO-1 for clinical trials. [Biotechnol Prog. 2011]
Expression and purification of cGMP grade NY-ESO-1 for clinical trials.
Lowe AJ, Bardliving CL, Huang CJ, Teixeira LM, Damasceno LM, Anderson KA, Ritter G, Old LJ, Batt CA. Biotechnol Prog. 2011 Mar-Apr; 27(2):435-41. Epub 2011 Mar 1.
Expression and purification of the cancer antigen SSX2: a potential cancer vaccine. [Protein Expr Purif. 2007]
Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.
Huang CJ, Chen RH, Vannelli T, Lee F, Ritter E, Ritter G, Old LJ, Batt CA. Protein Expr Purif. 2007 Dec; 56(2):212-9. Epub 2007 Aug 24.
Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast. [Protein Expr Purif. 2006]
Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast.
Piatesi A, Howland SW, Rakestraw JA, Renner C, Robson N, Cebon J, Maraskovsky E, Ritter G, Old L, Wittrup KD. Protein Expr Purif. 2006 Aug; 48(2):232-42. Epub 2006 Mar 2.
Review [NY-ESO-1 and cancer immunotherapy]. [Zhongguo Yi Xue Ke Xue Yuan Xu...]
Review [NY-ESO-1 and cancer immunotherapy].
Peng JR, Leng XS. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug; 30(4):371-7.
Review NY-ESO-1 immunotherapy for multiple myeloma. [Leuk Lymphoma. 2006]
Review NY-ESO-1 immunotherapy for multiple myeloma.
Szmania S, Tricot G, van Rhee F. Leuk Lymphoma. 2006 Oct; 47(10):2037-48.

See reviews... See all...

Cited by 3 PubMed Central articles

Inducing efficient cross-priming using antigen-coated yeast particles. [J Immunother. 2008]
Inducing efficient cross-priming using antigen-coated yeast particles.
Howland SW, Tsuji T, Gnjatic S, Ritter G, Old LJ, Wittrup KD. J Immunother. 2008 Sep; 31(7):607-19.
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. [Cancer Immun. 2007]
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Uenaka A, Wada H, Isobe M, Saika T, Tsuji K, Sato E, Sato S, Noguchi Y, Kawabata R, Yasuda T, et al. Cancer Immun. 2007 Apr 19; 7:9. Epub 2007 Apr 19.
Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway. [Protein Sci. 2006]
Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway.
Fisher AC, Kim W, DeLisa MP. Protein Sci. 2006 Mar; 15(3):449-58. Epub 2006 Feb 1.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP cond...
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.
Prep Biochem Biotechnol. 2005 ;35(2):119-34.

PubMed
Six-part series on the state of the RN workforce in the United States.
Six-part series on the state of the RN workforce in the United States.
Nurs Econ. 2005 Mar-Apr ;23(2):58-60, 55.

PubMed
Evaluation of bacterial polysaccharide immune globulin for the treatment or prev...
Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
J Infect Dis. 1992 Jun ;165 Suppl 1:S129-33.

PubMed
Iron acquisition in Haemophilus influenzae: receptors for human transferrin.
Iron acquisition in Haemophilus influenzae: receptors for human transferrin.
J Infect Dis. 1992 Jun ;165 Suppl 1:S103-4.

PubMed
[Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cel...
[Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway].
Yao Xue Xue Bao. 2005 Jan ;40(1):27-31.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information